Bristol-Myers Squibb-CVRPreferred / convertible
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Bristol-Myers Squibb-CVR in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Beddow Capital Management Inc. ($0).
- Company
- Bristol-Myers Squibb-CVR
- CUSIP
- 110122157
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 7,000 shares sold, net −7,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Beddow Capital Management Inc. | — | Reduce -1.3% | 553,789 | $0 |
"% of holder's portfolio" is BRISTOL-MYERS SQUIBB-CVR's weight in each manager's 13F, not the share of Bristol-Myers Squibb-CVR the manager owns.